Launch a Weight Loss & Obesity Medicine Telehealth Service Line
Longitudinal weight management that combines anti-obesity pharmacotherapy, metabolic screening, and lifestyle and behavioral coaching on one funnel. TelePartners Studio helps partners launch and operate this service line on one telehealth operating model.
The highest-volume category in telehealth
Weight loss and obesity medicine is the longitudinal management of overweight and obesity, combining anti-obesity pharmacotherapy, metabolic screening, and lifestyle and behavioral coaching. It is typically the highest-volume, highest-revenue telehealth vertical.
It pairs well with metabolic health and diagnostics offerings. TelePartners Studio provides the patient acquisition, intake, provider network access, lab integration, and pharmacy fulfillment around it. New to the model? See how TelePartners Studio works or read about us.
What your weight loss service line can cover
Anti-obesity pharmacotherapy
Clinician-directed programs using GLP-1 and dual GIP/GLP-1 agonists and other options, per each partner's formulary.
Metabolic screening
Baseline labs, including CMP, HbA1c or fasting glucose, lipid panel, and TSH, before therapy starts.
Lifestyle & behavioral coaching
Coaching built into the program alongside pharmacotherapy.
Contraindication screening
Required history screen for medullary thyroid carcinoma and MEN 2 before GLP-1/GIP therapy.
Baseline measurements
Weight, BMI, waist circumference, and blood pressure captured at intake.
Refills & follow-up
Recurring visits and refill workflows for longitudinal, subscription-style programs.
How the service line runs through the TelePartners Studio model
Patient Acquisition
Social content and Meta ads for weight management, reviewed against advertising rules before they run.
Landing Page
A landing page that explains the program and the steps to get started.
Intake & Checkout
Intake captures health history, baseline weight, BMI, waist circumference, blood pressure, and required contraindication screening before payment and booking.
Provider Video Visit
A licensed clinician reviews the intake and baseline labs, by synchronous audio-video where a controlled substance is being considered.
Prescription When Appropriate
The clinician decides independently whether pharmacotherapy is appropriate and which option fits the patient.
Pharmacy Fulfillment
A network pharmacy fills and ships the order. Compounded products come only from state-licensed 503A/503B pharmacies, and only when the FDA shortage exception applies.
Labs are typically ordered before therapy starts and repeated periodically through the Diagnostics & Lab Work Integration layer.
The components behind this service line
Medications and labs below are illustrative, drawn from the TelePartners Studio Service Line Reference Guide. Each partner's independent medical director finalizes the formulary, lab panels, and visit protocols.
Medication classes
GLP-1 receptor agonists, dual GIP/GLP-1 agonists, naltrexone/bupropion, phentermine/topiramate ER, phentermine, and metformin as an adjunct, per each partner's formulary.
Baseline labs
Comprehensive metabolic panel, HbA1c and/or fasting glucose, lipid panel, and TSH to rule out thyroid-driven weight change.
Pregnancy screening
Pregnancy testing for patients who can become pregnant before GLP-1/GIP initiation and periodically after.
Pancreatic history review
Lipase and pancreatic history review if prior pancreatitis is reported.
Standing lab orders
A GLP-1 initiation panel that a provider can trigger with one click after the visit.
Pharmacy fulfillment
Network pharmacies fill each order and ship it directly to the patient.
What to plan for before this service line goes live
Controlled substances
Phentermine and phentermine-combination products are DEA Schedule IV. Several states restrict initiating Schedule III–V prescriptions via audio-only telehealth, and some require an in-person exam within a defined period.
Compounding & FDA shortage lists
Many GLP-1/GIP formulations are non-controlled but frequently appear on FDA shortage lists, which affects whether compounding is permissible at all.
Contraindication screening
A personal and family history screen for medullary thyroid carcinoma and MEN 2 is mandatory before GLP-1/GIP therapy.
Marketing claims
Social content, ads, and landing pages for prescription products should be reviewed for FTC/FDA advertising compliance and state direct-to-consumer rules.
Corporate practice of medicine
Partners should operate through a compliant physician-owned professional entity or MSO structure, with TelePartners Studio's technology and marketing role kept separate from clinical decision-making.
Final state-specific requirements, formularies, protocols, and coverage should be reviewed by the appropriate medical and legal professionals before launch. TelePartners Studio provides technology, marketing, and operational support. It does not practice medicine or provide legal advice, and every prescribing decision is made independently by the treating licensed clinician.
Run your highest-volume service line on one funnel
Related service lines: Metabolic & Cardiometabolic Health·Diagnostics & Lab Work Integration·Men's Health
Ready to launch this telehealth service line?
Talk with TelePartners Studio about building and launching a weight loss service line in your target market.
Book a Discovery Call